Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HNRNPDL pseudogene 4 (HNRNPDLP4) is a non-functional, non-protein-coding genomic sequence similar to the HNRNPDL gene.\nPseudogenes like HNRNPDLP4 arise from duplication or retrotransposition events and usually do not produce protein products. No published evidence links this pseudogene to cellular biological functions, diseases, or utility as a therapeutic target. The functional HNRNPDL gene encodes a heterogeneous nuclear ribonucleoprotein D-like protein involved in RNA binding and alternative splicing regulation[1][2][6], but these properties do not apply to the pseudogene.\nFor experimental or clinical purposes, HNRNPDLP4 should not be considered a direct therapeutic or diagnostic target.\n\nNote: If you meant the functional gene HNRNPDL rather than the pseudogene, please clarify, as HNRNPDL is a validated protein and may have therapeutic and disease relevance[1][2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HNRNPDL pseudogene 4 (HNRNPDLP4).